1. Home
  2. EVCM vs HRMY Comparison

EVCM vs HRMY Comparison

Compare EVCM & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVCM
  • HRMY
  • Stock Information
  • Founded
  • EVCM 2006
  • HRMY 2017
  • Country
  • EVCM United States
  • HRMY United States
  • Employees
  • EVCM N/A
  • HRMY N/A
  • Industry
  • EVCM EDP Services
  • HRMY Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVCM Technology
  • HRMY Health Care
  • Exchange
  • EVCM Nasdaq
  • HRMY Nasdaq
  • Market Cap
  • EVCM 1.7B
  • HRMY 1.8B
  • IPO Year
  • EVCM 2021
  • HRMY 2020
  • Fundamental
  • Price
  • EVCM $10.02
  • HRMY $34.94
  • Analyst Decision
  • EVCM Buy
  • HRMY Strong Buy
  • Analyst Count
  • EVCM 12
  • HRMY 9
  • Target Price
  • EVCM $11.67
  • HRMY $55.33
  • AVG Volume (30 Days)
  • EVCM 188.4K
  • HRMY 627.0K
  • Earning Date
  • EVCM 08-06-2025
  • HRMY 08-05-2025
  • Dividend Yield
  • EVCM N/A
  • HRMY N/A
  • EPS Growth
  • EVCM N/A
  • HRMY 58.41
  • EPS
  • EVCM N/A
  • HRMY 3.10
  • Revenue
  • EVCM $703,186,000.00
  • HRMY $772,527,000.00
  • Revenue This Year
  • EVCM N/A
  • HRMY $20.45
  • Revenue Next Year
  • EVCM $6.31
  • HRMY $17.32
  • P/E Ratio
  • EVCM N/A
  • HRMY $11.29
  • Revenue Growth
  • EVCM 7.84
  • HRMY 17.74
  • 52 Week Low
  • EVCM $8.10
  • HRMY $26.47
  • 52 Week High
  • EVCM $12.34
  • HRMY $41.61
  • Technical
  • Relative Strength Index (RSI)
  • EVCM 38.32
  • HRMY 50.27
  • Support Level
  • EVCM $9.95
  • HRMY $34.09
  • Resistance Level
  • EVCM $11.70
  • HRMY $36.09
  • Average True Range (ATR)
  • EVCM 0.45
  • HRMY 1.42
  • MACD
  • EVCM -0.18
  • HRMY -0.19
  • Stochastic Oscillator
  • EVCM 3.61
  • HRMY 46.42

About EVCM EverCommerce Inc.

EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is primarily generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: